Mouse oocytes undergo two successive meiotic divisions to generate one large egg with two small polar bodies. The divisions are essential for preserving the maternal resources to support embryonic development. Although previous studies have shown that some small guanosine triphosphatases, such as RAC, RAN, and CDC42, play important roles in cortical polarization and spindle pole anchoring, no oocytes undergo cytokinesis when the mutant forms of these genes are expressed in mouse oocytes. Here, we show that the ADP-ribosylation factor 1 (ARF1) plays an important role in regulating asymmetric cell division in mouse oocyte meiosis. Microinjection of mRNA of a dominant negative mutant form of Arf1 (Arf1
INTRODUCTION
Asymmetric cell division refers to a mother cell dividing into two daughter cells with different cell fates, and it is involved in multiple biological processes. Asymmetric cell division is crucial for generating diversity of development and for self-renewal of stem cells. In early embryo development in mammals, the totipotent blastomeres undergo asymmetric cell divisions to generate the earliest cell lineage differentiation.
During adult stem cell division, one daughter cell maintains pluripotency, and the other daughter cell differentiates into a specific cell type through asymmetric cell division. Asymmetric cell division can be manifested by symmetric spindle positioning coupled with asymmetric distribution of cell fate determinants to generate two equally sized daughter cells with different fates, or asymmetric spindle positioning to generate two unequally sized daughter cells with different fates. The asymmetric cell division in mouse oocyte meiosis belongs to the second situation. In mammalian female meiosis, the oocyte undergoes typical asymmetric cell divisions to generate a large oocyte and two small polar bodies with different destinations. It has been demonstrated previously that PAR proteins and small G proteins function in this process [1] [2] [3] [4] . The oocyte polarity is acquired along with spindle positioning and anchoring to the cortex, which is controlled by actin and tubulin [5] .
Female meiosis in mammals is characterized by the generation of a single, large, haploid oocyte and two small polar bodies through two successive asymmetric cell divisions without intervening DNA replication. Fertilization unites a haploid sperm with the large oocyte to initiate early embryo development. The mechanism responsible for driving this extremely asymmetric cell division in female meiosis is poorly understood. Immature mammalian oocytes within ovarian follicles are arrested in prophase I with a centrally located large nucleus called a germinal vesicle (GV) . In response to a luteinizing hormone (LH) surge in the animal, or when isolated from the ovarian follicles, the oocyte will undergo asymmetric cell division to release the first polar body and arrest at metaphase II (MII). In mature oocytes, the MII spindle is oriented parallel to the cortex, and upon fertilization or parthenogenetic activation, rotation of the MII spindle for 90 degrees by an unknown mechanism facilitates the extrusion of the second polar body [6] .
Several recent studies have indicated that small guanosine triphosphatases (GTPases), such as RAN, RAC, and CDC42, likely play important roles in metaphase spindle assembly, anchoring of the spindle to the cortex, and polar body extrusion. However, when these GTPases are inhibited, the affected oocytes either exhibit abnormal spindle assembly [7] [8] [9] or fail cytokinesis [10] . Therefore, it remains unclear whether any of these GTPases are directly involved in asymmetric spindle positioning.
Here, we provide evidence that ADP-ribosylation factor 1 (ARF1), one small GTPase, plays an important role in regulating asymmetric cell division in female meiosis in the mouse. By expressing the dominant negative mutant form ARF1 T31N in both GV and MII oocytes, we found that a large proportion of oocytes underwent symmetric cell division and generated two oocytes of equal size. Furthermore, mitogenactivated protein kinase (MAPK) was inactivated in ARF1 T31N -expressing oocytes; however, MDK activity was not influenced. We propose that the ARF1-MAPK pathway regulates the asymmetric cell division in meiosis I, which is similar to previous findings that MOS (c-Mos)-MDK-MAPK [11, 12] functions in asymmetric cell division in meiosis I; however, regulation of MAPK activity by ARF1 was first demonstrated in the present study. Inhibition of MII spindle rotation for 90 degrees was found in ARF1 T31N -expressing MII oocytes when activation was induced via parthenogenetic activation or sperm injection. These data strongly indicate that ARF1 regulates asymmetric cell division in female meiosis in mammals.
MATERIALS AND METHODS
Animals, Oocyte Collection, Chemical Treatment, Parthenogenetic Activation, and Intracytoplasmic Sperm Injection
The specific pathogen-free-grade hybrid mice B6D2F1 (C57BL/63DBA/2) were housed in the animal facility of the National Institute of Biological Sciences. All studies adhered to procedures consistent with the National Institute of Biological Sciences guide for the care and use of laboratory animals. All inorganic and organic compounds were purchased from Sigma Chemical Company (St. Louis, MO) unless otherwise stated.
Fully grown GV oocytes were collected from 4-to 8-wk-old B6D2F1 female mice 44-48 h after equine chorionic gonadotropin injection. The antral follicles were punctured by 30-gauge needles, and the GV oocytes enclosed by several layers of cumulus cells were selected for the following experiments. The cumulus cells were mechanically removed, and the denuded oocytes were cultured in Waymouth medium supplemented with 10% fetal bovine serum and 0.23 mM pyruvate acid at 378C under 5% CO 2 [13] .
The chemicals used for destroying the Golgi apparatus of oocytes were brefeldin A (BFA) and Exo1, and the concentrations used were 5 and 20 lM, respectively. To inhibit spontaneous GV breakdown, 10 lM of milrinone was supplemented in the culture medium.
The MII oocytes were collected from the oviducts of 8-to 10-wk-old female mice administrated with equine chorionic gonadotropin and human chorionic gonadotropin. Parthenogenetic activation of MII oocytes was performed by culture of the oocytes in calcium-free CZB medium supplemented with 10 mM strontium. Intracytoplasmic sperm injection (ICSI) was performed according to a previous report [14] ; a single sperm head was microinjected into the MII oocyte assisted by a piezo-drill micromanipulator at room temperature.
Construction of Arf1
T31N , Arf1
Q71L
, Arf3 T31N , and Arf6
T27N

Mutants and Microinjection
The mRNA of GV oocytes was extracted with Dynabeads mRNA DIRECT Kit (Invitrogen). Sequences of all plasmid clones were sequence verified. To investigate the expression of Arf1 mRNA in mouse oocytes and early-stage embryos, PCR was performed with forward primer F3 gaagatctATGGGGAA-TATCTTTGCAAACCTC and reverse primer R5 ccgctcgagCTTCTG GTTCCGGAGCTG. For construction of dominant negative mutant form of Arf1 (Arf1 T31N ), the first PCR was performed with forward primer F3 and reverse primer R3 GTTTGTATAGAATTGTgtTCTTCCC. The other PCR employed forward primer F4 GGGAAGAacACAATTCTATACAAAC and reverse R5. The italic ac represents the mutated bases. Both PCR products were gel purified before use as templates for the second PCR with primers F3 and R5 to synthesize full-length ARF1 T31N . The PCR product was digested with BglII and XhoI and ligated into a vector that had been digested with BglII and XhoI.
For construction of the dominant active form of Arf1 (Arf1
Q71L
), reverse primer R3 CAGGGGCCGGATCTTGTCCAGGCCGCCCACATCCC and forward primer F4 GGGATGTGGGCGGCCTGGACAAGATCCGGCCCCTG were used. In vitro RNA synthesis was performed using mMESSAGE mMACHINE T3 (Ambion) and stored at À808C. Equal quantities of mRNAs were microinjected into the cytoplasm of oocytes using an Eppendorf Femtojet microinjector.
The method used for construction of Arf3 dominant negative mutant (Arf3
T31N
) was essentially the same as for Arf1. The forward primer F3 was gaagatctATGGGCAATATCTTTGGGAACC, and the reverse primer R5 was ccgctcgagCTTCTTGTTTTTGAGCTGATTGGCC. The forward primer F4 was GGGAAGAaCACCATCCTCTACAAGC, and the reverse primer R3 was GCTTGTAGAGGATGGTGtTCTTCCC.
For construction of Arf6 dominant negative mutant (Arf6 T27N ), the method was the same as Arf1, except that the enzymes used were XhoI and SacI. The forward primer F3 was CATCTCGAGATGGGGAAGGTGCTATCC, and the reverse R5 was CATGAGCTCGGATTTGTAGTTAGAGGTT. The forward primer F4 was CGCAGCCGGCAAGAATACGATCCTGTACAAGTTG, and the reverse R3 was CAACTTGTACAGGATCGTATTCTTGCCGGCTGCG.
Western Blotting
To investigate MAPK activity in the oocytes from different treatments, proteins from 150 oocytes were collected in the SDS sample buffer and boiled at 1008C for 5 min. After cooling on ice and centrifuging at 12 000 3 g for 5 min, the samples were kept at À808C until use. The total proteins were separated by SDS-PAGE and electrophoretically transferred to the polyvinylidene fluoride (PVDF) membrane at 48C. The transferred PVDF membrane then was blocked in TBST buffer containing 5% nonfat milk at 48C overnight. To detect the phosphorylated MAPK, the blocked PVDF membrane was incubated with 1:500 rabbit anti-phosphorylated MAPK (Promega) overnight at 48C. After three washings with TBST (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.05% Tween-20), the membrane was incubated with horseradish peroxidase-conjugated goat anti-rabbit second antibody (Amersham Pharmacia) for 2 h at room temperature. The membrane was extensively washed with TBST three times and then processed with the ECL detection system (Amersham).
To reprobe the membrane with the anti-MAPK1 antibody to detect the existence of total MAPK, the membrane was washed in the stripping buffer (100 mM b-mercaptoethanol, 20% SDS, and 62.5 mM Tris [pH 6.7]) at 508C for 30 min to strip off the bound antibodies after the first ECL detection. The stripped membrane then was reprobed with the polyclonal rabbit anti-MAPK1 antibody (Santa Cruz Biotechnology) using the procedures described above. All Western blot experiments were repeated at least three times. The methods used for detection of MDK activity were essentially the same as for active MAPK, and MAPK1 was detected as an internal control. The first antibody to phosphorylated MDK was purchased from SAB Signalway Antibody Company.
Immunocytochemistry Staining and Confocal Microscopy
The method used for indirect immunofluorescence staining was modified according to previous reports. All steps were performed at room temperature unless otherwise mentioned. The collected oocytes were fixed with 4% paraformaldehyde for at least 20 min and then permeabilized for 30 min with 0.2% Triton X-100 in PBS. After three washings, all samples were incubated in the blocking solution (10% normal goat serum and 0.05% Tween-20 in PBS) overnight at 48C. Oocytes were incubated with anti-a-tubulin primary antibody at a dilution of 1:1500 (Sigma) or anti-phosphorylated MAPK at a dilution of 1:500 (Promega) for 2 h at 378C. After three washings, the oocytes were incubated with a fluorescein isothiocyanate-conjugated goat anti-mouse secondary antibody (1:2000; Jackson ImmunoResearch) for 1 h for tubulin, or goat anti-rabbit conjugated to Alexa 594 (1:2000; Sigma) for phosphorylated MAPK. After washing, the oocytes were incubated with rhodamin phalloidin (Molecular Probes) to detect the microfilaments (actin). Finally, the DNA was stained with 4 0 6-diamidino-2-phenylindole (1 lg/ml), and all of the samples were mounted in anti-fade solution. Detection of Golgi morphology in GV oocytes was performed using the anti-GM130 antibody (BD Biosciences). At least 10 oocytes were processed for each separate sample, and the experiments were replicated at least three times. Stained oocytes mounted on slides were observed on an LSM 510 META confocal microscope (Zeiss) using Plan Neofluar 633/1.4 oil DIC objective and excitation wavelengths of 488, 405, and 594 nm. Collection of each channel signal was done sequentially. For each experiment, the same detector gain, amplifier offset, and pinhole parameters were used. All collected images were assembled using Adobe Photoshop software (Adobe Systems, San Jose, CA) without any adjustment of contrast and brightness to the images.
RESULTS
ARF1 T31N Expression Causes Symmetric Cell Division in Meiosis I
Recently, a study reported that brefeldin A (BFA)-treated oocytes could undergo symmetric cell division to generate two MII oocytes with similar sizes instead of a large oocyte alongside a polar body [15] . BFA could cause ARF1 inactivation [16] , leading to Golgi collapse [17, 18] . To 556 address whether the symmetric cell division in BFA-treated oocytes is the result of Golgi collapse, we treated the immature GV oocytes with another drug, Exo1, which destroys the Golgi apparatus via a different mechanism [19] . Exo1 did not affect the ARF1-GTP loading step. Our results indicated that all of the Exo1-treated oocytes underwent normal meiosis, producing a large oocyte alongside a polar body, although disruption of Golgi could be observed clearly in the treated oocytes (Supplemental Fig. S1 and all other supplemental data are available online at www.biolreprod.org). After excluding Golgi collapse as responsible for asymmetric oocyte division, subsequent experiments were performed to address whether ARF1 was indeed the target of BFA in converting polar body extrusion to symmetric cell division in mouse oocyte meiosis.
First, RT-PCR was performed to investigate whether Arf1 is expressed in the oocyte. Our results indicated that Arf1 mRNA is ubiquitously expressed at all the stages in oocytes and early embryos (Fig. 1A) , which is consistent with a previous report in which Arf1 expression in mouse oocytes was detected by microarray [20] . Subsequently, we expressed GFP-tagged ARF1 Q71L , via mRNA microinjection, in immature oocytes to determine its subcellular localization during oocyte maturation, because no specific antibodies are available to recognize the endogenous active form of ARF1 protein. The active form of ARF1 Q71L -GFP derived from the injected mRNA was found to be evenly distributed in the cytoplasm before and after GV breakdown (GVBD). ARF1 was found concentrated at the contractile ring and colocalized with F-actin during polar body extrusion (Fig. 1B) . Overexpression of ARF1 in oocytes showed no adverse effects on spindle anchoring to the cortex and polar body extrusion.
To address whether inhibition of ARF1 in GV oocytes will result in symmetric cell division in meiosis I, mRNA encoding a dominant negative mutant form of Arf1 (Arf1 T31N ) was microinjected into the cytoplasm of GV oocytes in the presence of milrinone, which is a phosphodiesterase inhibitor and can inhibit spontaneous GVBD [21] . Germinal vesicle oocytes expressing ARF1 T31N were allowed to undergo maturation. In contrast to control oocytes, which produced a large oocyte alongside a polar body ( Fig. 2A) , oocytes expressing ARF1 T31N underwent symmetric cell division and generated two half-sized oocytes (Fig. 2B) . To investigate cytokinesis in meiosis I in more detail, we carried out immunocytochemical staining of the oocytes at various stages of maturation. As shown in Figure 2C , following GVBD chromatins condensed into chromosomes and microtubules organized into a barrelshaped metaphase I (MI) spindle, the MI spindle migrated to the cortex, and the actin cap formed subsequently in the control oocyte. Then, one pole of the MI spindle was attached to the cortex (rotation of the MI spindle for 90 degrees might occur in this process), and the first polar body was extruded. In contrast, ARF1 T31N -expressing oocytes exhibited two phenotypes, both of which resulted in generating two half-sized MII oocytes. In the first category, the MI spindle remained at the center of the oocyte at the time anaphase initiated and furrowing progressed, which resulted in a cleavage midway through the oocyte. Both half-sized oocytes then progressed to MII and arrested at this stage (Fig. 2D) . Most ARF1 T31N -expressing oocytes fell into this category; the failure of spindle migration was found in 88.6% 6 2% (n ¼ 320) of the ARF1 T31N -expressing oocytes. In the second category, the MI spindle migrated to the cortex, accompanied by the appearance of an actin cap close to the cortically localized spindle. However, the MI spindle could not attach to the cortex to extrude polar bodies. Instead, a cleavage furrow started to form from the cortex close to the MI spindle; along with the cleavage furrow falling inside, the MI spindle moved to the opposite side of the cortex. The other cleavage furrow was induced, and the oocyte symmetrically divided consequently (Fig. 2E) . A very small proportion of ARF1 T31N -expressing oocytes fell into this category, with only 11.3% 6 2% (n ¼ 320) of oocytes observed.
ARF1 T31N Causes Symmetric Cell Division in Meiosis II
To investigate whether ARF1 also is involved in asymmetric cell division in the second meiosis, superovulated MII oocytes were injected with Arf1 T31N mRNA and then subjected to parthenogenetic activation or ICSI. Apparently, the control MII oocytes extruded second polar body following parthenogenetic activation (Fig. 3A) ; in contrast, the ARF1 T31N -expressing MII oocytes underwent symmetric cell division, producing two cells of similar size following parthenogenetic activation (Fig. 3B ). Subsequently, a pronucleus was observed in each of the two cells, suggesting successful egg activation. Immunocytochemistry staining was performed to investigate the cytoskeletal dynamics in this process. Following parthenogenetic activation, the MII spindle in the control oocyte rotated 90 degrees to become perpendicular to the cortex. Subsequently, a polar body was extruded, and a pronucleus was observed in the egg (Fig. 3C) . In contrast, in the ARF1 T31N -expressing MII oocytes, the spindle did not rotate and remained parallel to the cortex at the time anaphase initiated. Two actin caps were induced by the two sets of sister chromatids, and a cleavage furrow started to form and ingress. Following the cell cycle progression, the spindle was extensively stretched, and the cleavage furrow fell further into the oocyte to push the spindle to the opposite cortex. Subsequently, the oocyte cleaved into two oocytes of equal size, and each oocyte exhibited one visible pronucleus (Fig. 3D) .
FIG. 1. Expression and localization of ARF1 in mouse oocytes. A)
Reverse transcription-PCR analysis of expression of Arf1 mRNA in oocytes and early embryos. Blast, blastocyst. B) Localization of dominant active ARF1 (ARF1 Q71L ) in the mouse oocyte during maturation. Top row: ARF1 was distributed evenly in the cytoplasm of GV oocyte; middle row: ARF1 was evenly in the cytoplasm of GVBD oocyte; and bottom row: localization of ARF1 was concentrated at the contractile ring during polar body extrusion (arrow); bar ¼ 10 lm.
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To determine whether fertilization of the ARF1 T31N -expressing MII oocytes could also result in symmetric cell division, ICSI was performed according to a previous report [14] . As shown in Supplemental Figure S2 , the control MII oocyte released a second polar body, and two pronuclei were observed following ICSI. In striking contrast, the ARF1 T31N -expressing MII oocyte underwent symmetric cell division, similarly to that observed in parthenogenetic activation (Fig.   FIG. 3 
3D
). However, two pronuclei (one from the sperm) could be observed in one daughter oocyte, whereas the other oocyte contained only one pronucleus. Following culture in vitro, the ICSI-produced embryos could develop to blastocysts efficiently, whereas the ARF1 T31N -expressing oocyte-derived embryos could not undergo mitosis (Supplemental Fig. S3 ).
Generation of a Four-Cell Zygote from One ARF1 T31N -Expressing GV Oocyte
To investigate whether the two MII oocytes of equal size generated from the ARF1 T31N -expressing GV oocyte could undergo the second round of symmetric cell division in meiosis II, parthenogenetic activation and ICSI were performed as described above. As shown in Figure 4A , most two-cell MII oocytes underwent the second round of symmetric cell division and generated a four-cell, parthenogenetically activated oocyte 6 h after activation. Next, ICSI was performed to microinject a sperm head into each MII oocyte generated in meiosis I to investigate whether the sperm-triggered activation could lead to the same consequence. As shown in Figure 4B , both MII oocytes surviving after ICSI did undergo symmetric cell division after sperm injection, which is similar to what we observed in parthenogenetic activation.
ARF1 T31N Expression Causes Mitosis Failure
Next, we sought to address whether the mutant embryos generated from either ARF1 T31N -expressing GV oocytes or MII oocytes could undergo mitosis and develop to the blastocyst stage. The results indicated that no embryos could undergo normal mitosis, and all the embryos were developmentally arrested (Supplemental Fig. S3 ). Our results coincided with a previous report in which expression of ARF1 T31N in the root meristem of Arabidopsis caused cell cytokinesis defects [22] . However, the symmetrically divided oocytes generated from BFA treatment could undergo normal mitosis and develop to blastocyst stage once BFA was removed (our unpublished data), which might provide a useful approach to investigate whether the two sets of homologous chromosomes are equivalent in development.
ARF3 and ARF6 Dominant Negative Mutant, ARF1 Constitutive Active Mutant Do Not Cause Symmetric Division in Meiosis
To investigate whether other members of the Arf family play similar roles in regulating asymmetric cell division in meiosis, Arf3 and Arf6 were selected. ARF3 is 97% identical to ARF1 in amino acid sequence. On the other hand, ARF6 is thought to be an important regulator of the actin cytoskeleton [23] . However, we found that neither the dominant negative mutant form of ARF3 T31N nor that of ARF6 T27N expression affected the first polar body extrusion (of oocytes) or the second polar body extrusion (of superovulated eggs; data not shown). And the constitutive active form of ARF1 (ARF1 Q71L )-expressing oocytes protruded the polar body, resembling the control oocytes (discussed above).
ARF1 Dominant Negative Mutant Causes MAPK Inactivation
Because microtubule organization appeared abnormal in the ARF1 T31N -expressing oocytes at the MI stage, the spindle was diffused compared with a normal MI spindle (Fig. 5) , we therefore focused subsequently on the pathways correlated with microtubule organization. It has been reported that the MOS-MDK-MAPK pathway plays an essential role in spindle organization [24, 25] and cell cycle progression in meiosis [12, [26] [27] [28] . Moreover, a small proportion of the oocytes collected from Mos knockout mice generated large polar bodies during meiosis [12] , which is similar to the phenomena observed in ARF1 T31N oocytes. Results from a previous study have shown that ARF6, the ARF family number, could regulate MDK/ MAPK signaling pathway [29] ; moreover, BFA, the ARF1 inhibitor, could inhibit MAPK activity in some cell lines [30] . Furthermore, most Mos mutant oocytes will undergo parthenogenetic activation spontaneously [26] [27] [28] . Based on these previous findings, we investigated MAPK activity in the symmetrically divided ARF1 T31N oocytes. As expected, we found phosphorylated MAPK in MII oocytes but not in GV oocytes (Fig. 6A) . Surprisingly, we found significantly reduced phosphorylated MAPK in the symmetrically divided ARF1 T31N oocytes compared with control MII oocytes (Fig.  6A , compare the second and third lanes). To further observe whether the symmetrically divided ARF1 T31N MII oocytes contain the similar localization of phosphorylated MAPK to normal MII oocytes, we performed immunocytochemistry staining. Our results showed that localization of phosphorylated MAPK in the metaphase spindle could be observed clearly in the control MII oocytes. However, no active phosphorylated MAPK could be detected on the metaphase spindle in the symmetrically divided ARF1 T31N MII oocytes (Fig. 6B ). Although the symmetrically divided ARF1 T31N MII oocytes were arrested at metaphase (Fig. 2) , they appeared to be undergoing spontaneous activation in vitro more easily. After 9 h of culture, pronuclei were observed in most symmetrically divided ARF1 T31N oocytes. However, very few control MII oocytes were spontaneously activated under the same condi- 
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tions (Fig. 6C) . We further investigated whether MDK activity could be inactivated in ARF1
T31N
-expressing oocytes during meiosis I, and the Western blot results indicated that MDK activity was not affected at all (Fig. 6D) . Therefore, our results indicated that ARF1 regulates MAP kinase activity without affecting the upstream kinases of MOS pathway. In contrast to ARF1 T31N , ARF6 T27N or ARF3 T31N injection into the oocytes did not cause downregulation of MAPK activity, and the oocytes could undergo normal maturation (Supplemental Fig.  S4 ).
DISCUSSION
Asymmetric cell division plays an essential role in mammalian female meiosis to preserve maternal resources in the large oocyte generated to support further embryonic development. However, the underlying mechanism is poorly understood. Previous studies show that some small GTPases play important roles in maintaining the polarity of the oocyte. In the present study we provided evidence indicating that another small GTPase, ARF1, plays an essential role in regulating asymmetric cell division in oocyte meiosis in the mouse. By expressing the dominant negative mutant form of ARF1 (ARF1 T31N ) in GV or MII oocytes, we found the oocytes would undergo symmetric cell division to generate two oocytes with equal size both in meiosis I and meiosis II. Inactivation of MAPK has been observed in the symmetrically divided MII oocytes generated in meiosis I, which indicates that ARF1 might regulate asymmetric cell division through regulation of MAPK activity in meiosis I. Inhibition of MII spindle rotation has been observed in ARF1 T31N -expressing MII oocytes during meiosis II.
Regulation of MAPK activity by ARF1 in meiosis I, which did not work through MOS-MDK-MAPK parthway, was discovered in the present study. It has been shown previously that oocytes collected from Mos knockout mice could occasionally release large polar bodies during maturation. Because MAPK is regulated by MDK, downstream of MOS, we further analyzed the MDK activity as well in the ARF1 T31N -expressing oocytes. Our results indicated that the MDK activity was not affected and indicated that ARF1 regulates MAPK activity independently from the MOS-MDK-MAPK pathway. Our results demonstrated that MAPK activity could be regulated by ARF1 in mouse oocytes, and this pathway is a separate pathway from the MOS pathway. 
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However, it remains unsolved whether ARF1 interacts with MAPK directly or indirectly and, if indirectly, through which molecule regulating MAPK activity. Coincidentally with our finding, the results from a previous study have indicated that BFA treatment could cause inactivation of MAPK in some cell lines [30] . Further investigation of the direct targets of ARF1 for regulating MAPK activity and cytokinesis in mammalian oocytes is deserved. Interestingly, oocytes treated with BFA exhibit active MAPK [15] . However, because BFA-treated oocytes exhibited both one-cell and two-cell phenotypes (roughly 50% each), and MAPK was analyzed on the mixture, it is possible that the ''one-cell'' oocytes were largely responsible for the active MAPK signal [15] .
Prohibition of MII spindle rotation for 90 degrees was observed in ARF1 T31N -expressing MII oocytes, and the oocytes symmetrically divided following parthenogenetic activation or sperm injection. Regulating spindle rotation by ARF1 was suggested as responsible for asymmetric cell division in meiosis II. When the active form of ARF1 was expressed in mouse oocytes, localization of ARF1 dynamically changed from even distribution in the cytoplasm of GV oocytes to predominant distribution in the contraction ring of oocytes undergoing cytokinesis. Colocalization of ARF1 with actin was observed in the oocyte extruding polar body, and the results suggest that ARF1 might regulate spindle rotation by regulating actin organization or interaction with microtubules. However, further experiments need to be performed to verify the direct interaction between ARF1 and microfilament during spindle rotation in meiosis.
In addition to our findings, ARF1 has been found to affect cell polarity and the rotation of Fucus zygote division plane [31] . In Arabidopsis, apical-basal polarity of epidermal cells, reflected by the position of root hair outgrowth, is also affected when ARF1 mutants are expressed [22] .
Unlike ARF1
T31N
-expressing oocytes, the symmetrically divided oocytes generated by BFA treatment could undergo early embryo development after parthenogenetic activation or sperm injection if BFA was removed (our unpublished data). It could provide us with an invaluable system for investigation if the two sets of chromosomes are developmentally equivalent after homologous recombination and separation, although a previous study has indicated that first polar body could be used to generate live animals [32] . However, it could not exclude the possibility that the defect chromosomes could be selectively separated into the small polar body during meiosis I.
Recently, parthenogenetic embryo-derived embryonic stem cells have been proposed as a useful seed cell resource for providing major histocompatibility complex (MHC)-competent embryonic stem (ES) cells for transplantation-based treatment of certain diseases [33] . The symmetrically divided oocytes generated from BFA treatment would be able to produce ES cells containing all MHCs inherited from the oocyte. Further studies are proposed to investigate whether these ES cells generated could indeed widen the application scale.
In summary, the present study indicated that ARF1 plays a critical role in regulating asymmetric cell division in female meiosis both in meiosis I and meiosis II. Regulation of MAPK activity by ARF1 might be involved in asymmetric cell division in meiosis I. Regulation of MII spindle rotation and anchoring by ARF1 are proposed in meiosis II.
